Implications of the impact of prevalence on test thresholds and outcomes: Lessons from tuberculosis

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Bentley, Tanya Gk ^a   Catanzaro, Antonino ^b   Ganiats, Theodore G ^c  

^a PARTNERSHIP FOR HEALTH ANALYTIC RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Disease prevalence; Outcomes; Screening; Sensitivity; Specificity; Test thresholds; Testing; Tuberculosis

Indexed keywords

ARTICLE; HUMAN; PREVALENCE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

HUMANS; PREVALENCE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 84869825241     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-563     Document Type: Article

References (20)

1. Hunink M, Glasziou P, Siegel J, Weeks J, Pliskin J, Elstein A, Weinstein MC, Decision Making in Health and Medicine: Integrating Evidence and Values New York: Cambridge University Press 2001
2. Sox HC, Blatt MA, Higgins MC, Marton KI, Medical Decision Making Philadelphia: ACP Press 2007
3. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C, Arch Intern Med 2003 163 1009 1021 10.1001/archinte.163.9. 1009 12742798 (Pubitemid 36548927)
4. World Health Organization Stop TB Department, Global TB Database http://www.who.int/tb/country/global-tb-database/en/index.html?language
5. World Health Organization, Tuberculosis Facts http://www.who.int/entity/ tb/publications/2008/factsheet-april08.pdf
6. Cutting-edge science and the future of tuberculosis control. Brosch R, Vincent V, Bull World Health Organ 2007 85 410 412 17639231 (Pubitemid 46718380)
7. Diagnosis of pulmonary and extrapulmonary tuberculosis. Lam P, LoBue P, Perry S, Catanzaro A, In Reichman and Hershfield's Tuberculosis: A Comprehensive International Approach New York: Informa Healthcare USA, Inc, Raviglione MC, 3rd edition, Part A 2006 155 182 22325844
8. Centers for Disease Control and Prevention, Division of Tuberculosis Elimination, Tuberculin Skin Testing Fact Sheet http://www.cdc.gov/TB/pubs/ tbfactsheets/skintesting.htm
9. World Health Organization, HIV TB, Guidelines for intensified case finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings http://www.aidsdatahub.org/en/whats-new/287-all- data-alerts/582-who-2010-guidelines-for-intensified-tuberculosis-case-finding- and-isoniazid-preventive-therapy-for-people-living-with-hiv-in-resource- constrained-settings
10. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Dheda K, Van Zyl Smit R, Badri M, Pai M, Curr Opin Pulm Med 2009 15 188 200 10.1097/MCP.0b013e32832a0adc 19387262
11. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. Ransohoff DR, Feinstein AR, N Engl J Med 1978 299 926 930 10.1056/NEJM197810262991705 692598 (Pubitemid 9050459)
12. Cellestis Ltd, QuantiFERON®-TB Gold In-Tube Method [package insert] http://www.cellestis.com/IRM/Content/info.html 23166560
13. Oxford Immunotec, International Search Results, T-SPOT®.TB http://www.oxfordimmunotec.com/Default.aspx?DN=483,108,1,Documents& adxSearchText=package%20insert&start=10&l=English
14. Sackett D, Haynes R, Guyatt G, Tugwell P, Clinical epidemiology: a basic science for clinical medicine Boston: Little, Brown 2 1991
15. Meta-analysis of diagnostic accuracy studies accounting for disease prevalence: alternative parameterizations and model selection. Chu H, Nie L, Cole SR, Poole C, Stat Med 2009 28 2384 2399 10.1002/sim.3627 19499551
16. Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis. Leeflang MM, Bossuyt PM, Irwig L, J Clin Epidemiol 2009 62 5 12 10.1016/j.jclinepi.2008.04.007 18778913
17. Empirical evidence that disease prevalence may affect the performance of diagnostic tests with an implicit threshold: a cross-sectional study. Willis BH, BMJ Open 2012 2 000746 10.1136/bmjopen-2011-000746 22307105
18. Can Malawis poor afford free tuberculosis services? Patient and household costs associated with a tuberculosis diagnosis in Lilongwe. Kemp JR, Mann G, Simwaka BN, Salaniponi FM, Squire SB, Bull World Health Organ 2007 85 580 585 10.2471/BLT.06.033167 17768515 (Pubitemid 47333815)
19. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Diel R, Loddenkemper R, Nienhaus A, Chest 2010 137 952 968 10.1378/chest.09-2350 20022968
20. U.S. Department of Health & Human Services, U.S. Food and Drug Administration Summary of Safety and Effectiveness http://www.accessdata.fda. gov/cdrh-docs/pdf7/P070006b.pdf